New Drug Product: Trijardy XR
This slideshow shows drug information for Trijardy XR. Click here for the complete Trijardy XR monograph.
Diabetes
Gvoke HypoPen Now Available for Severe Hypoglycemia
Xeris Pharmaceuticals announced the launch of Gvoke HypoPen™ (glucagon) for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 2 years and older.
CDC Updates List of Who Is at Highest Risk for COVID-19
Agency now says risk among adults increases steadily with age, and is not limited to those over 65.
MPR Weekly Dose Podcast Episode 40
This week on the Pod: over-the-counter med recalls; a nasal spray approved for diabetic gastroparesis; reports of an uptick in penicillin-, ciprofloxacin-resistant meningococci; and in pandemic-related news, a possible inhaled version of remdesivir, and colchicine as a potential treatment.
FDA Approves Gimoti Nasal Spray for Diabetic Gastroparesis
The FDA has approved Gimoti™ (metoclopramide; Evoke Pharma) nasal spray for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis.
New Rapid-Acting Insulin Lyumjev Approved
The FDA has approved Lyumjev™ (insulin lispro-aabc injection; Lilly) to improve glycemic control in adults with type 1 and type 2 diabetes.
FreeStyle Libre 2 Cleared for Use in Adults and Pediatric Patients With Diabetes
The FDA has approved the FreeStyle® Libre 2 integrated continuous glucose monitoring system (Abbott) for adults and children ≥4 years of age with diabetes.
Long-Acting Insulin Analogue Semglee Approved
The FDA has approved Semglee™ (insulin glargine injection; Mylan and Biocon) to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
Adherence to Diabetes Meds May Cut Mortality in Colorectal Cancer
Patients with colorectal cancer and diabetes have better survival with adherence to diabetes meds.
FDA: Unacceptable NDMA Levels Identified in Certain Metformin ER Products
Specifically, unacceptable levels of this potentially carcinogenic impurity have been identified in products manufactured by 5 different firms.
